Global Pyrogen Testing Market

Pyrogen Testing Market Size, Share, Growth Analysis, By Product(Consumables, Instruments, and Services), By Test Type(LAL Test, Chromogenic Test, Turbidimetric Test, Gel Clot Test), By End-Use(Pharmaceutical and Biotechnology Companies, Medical Devices Companies, and Others), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35D2271 | Region: Global | Published Date: October, 2024
Pages: 176 | Tables: 93 | Figures: 71

Pyrogen Testing Market Insights

Global Pyrogen Testing Market size was valued at USD 1322.30 Million in 2022 and is poised to grow from USD 1499.48 Million in 2023 to USD 4100.59 Million by 2031, growing at a CAGR of 13.4% in the forecast period (2024-2031).

Pyrogen testing is a crucial process that ensures decontamination of diverse medical and pharmaceutical devices. The testing helps these instruments stay free from pyrogens – elements that may induce fever. The market has been progressing on the back of the rising awareness of patient safety, strict regulatory needs, and the growing production of pharmaceutical and biologics. The market is also driven by the increased focus on quality control, the need for compliance with international principles, and improvements in testing technologies. Nonetheless, the market is restrained by the constantly changing regulatory and compliance landscape and low awareness and adoption of the said procedure. Yet, the market is projected to witness significant growth over the forthcoming years owing to the growing digitalization and automation in testing processes and the expansion of biologics and biopharmaceuticals.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Pyrogen Testing Market size was valued at USD 1322.30 Million in 2022 and is poised to grow from USD 1499.48 Million in 2023 to USD 4100.59 Million by 2031, growing at a CAGR of 13.4% in the forecast period (2024-2031).

The global pyrogen testing market is a highly competitive global market driven by many international competitors. Prominent corporations with cutting-edge AI and ML technology are Google, IBM, Microsoft, and NVIDIA. To support a wide range of applications across industries, these industry experts concentrate on creating cutting-edge algorithms, scalable platforms, and reliable infrastructure. Rapid advances in technology, strategic alliances, and large expenditures on research and development define the competitive environment. 'Merck KGaA', 'GenScript', 'Hyglos GmbH', 'Ellab A/S', 'Lonza', 'Thermo Fisher Scientific, Inc.', 'Charles River Laboratories, Inc.', 'Associates of Cape Cod, Inc.', 'Pyrostar', 'Abbott Laboratories', 'AstraZeneca', 'Heraeus Medical', 'Wako Pure Chemical Industries', 'Roche Diagnostics', 'Biosafe Technologies'

The development of novel drug classes, advanced therapies and biologics, including gene therapies, monoclonal antibodies, and cell therapies is rigorously demanding highly efficient and reliable testing process for ensuring high efficacy and safety of complex products. Also, the increasing research and development activities in biotechnology and pharmaceutical industries is necessitating the demand for pyrogen testing in the growing volume of devices.

High-Throughput Screening and Automation: Integrating automation in pyrogen testing is improving accuracy and efficiency. The newly integrated automation systems can capably manage huge sample volumes and conduct tests with better consistency. This reduces operational costs and human errors. Also, improvements in high-throughput screening techniques enable speedy and exhaustive testing of several samples at the same time.

North America is currently dominating and is likely to continue so during the forecast period. This is owing to its well-developed healthcare infrastructure, growing investment in biotechnology and pharmaceutical research. The growth of this region is also significantly impacted by strong regulatory frameworks like the ones from the U.S. FDA and the presence of several established players in biotechnology and pharmaceutical companies. Furthermore, the regional growth is driven by the growing number of research and development activities and improvements in testing. These factors contribute to the growth of the market in North America. The key players operating in the region include Charles River Laboratories, Lonza Group, BioTek Instruments, Thermo Fisher Scientific, Vortex Biosciences, and more.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Feedback From Our Clients

Global Pyrogen Testing Market

Report ID: SQMIG35D2271

$5,300
BUY NOW GET FREE SAMPLE